350 related articles for article (PubMed ID: 10816419)
1. Tyrosine phosphorylation of the vascular endothelial-growth-factor receptor-2 (VEGFR-2) is modulated by Rho proteins.
Gingras D; Lamy S; Béliveau R
Biochem J; 2000 Jun; 348 Pt 2(Pt 2):273-80. PubMed ID: 10816419
[TBL] [Abstract][Full Text] [Related]
2. VEGF-induced activation of phosphoinositide 3-kinase is dependent on focal adhesion kinase.
Qi JH; Claesson-Welsh L
Exp Cell Res; 2001 Feb; 263(1):173-82. PubMed ID: 11161716
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS
J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
[TBL] [Abstract][Full Text] [Related]
4. The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.
Béliveau R; Gingras D; Kruger EA; Lamy S; Sirois P; Simard B; Sirois MG; Tranqui L; Baffert F; Beaulieu E; Dimitriadou V; Pépin MC; Courjal F; Ricard I; Poyet P; Falardeau P; Figg WD; Dupont E
Clin Cancer Res; 2002 Apr; 8(4):1242-50. PubMed ID: 11948139
[TBL] [Abstract][Full Text] [Related]
5. Vascular permeability factor/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium.
Mukhopadhyay D; Nagy JA; Manseau EJ; Dvorak HF
Cancer Res; 1998 Mar; 58(6):1278-84. PubMed ID: 9515816
[TBL] [Abstract][Full Text] [Related]
6. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.
Joukov V; Pajusola K; Kaipainen A; Chilov D; Lahtinen I; Kukk E; Saksela O; Kalkkinen N; Alitalo K
EMBO J; 1996 Jan; 15(2):290-98. PubMed ID: 8617204
[TBL] [Abstract][Full Text] [Related]
7. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
Lu D; Jimenez X; Zhang H; Wu Y; Bohlen P; Witte L; Zhu Z
Cancer Res; 2001 Oct; 61(19):7002-8. PubMed ID: 11585724
[TBL] [Abstract][Full Text] [Related]
8. The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts.
Takahashi T; Shibuya M
Oncogene; 1997 May; 14(17):2079-89. PubMed ID: 9160888
[TBL] [Abstract][Full Text] [Related]
9. The adapter protein, Grb10, is a positive regulator of vascular endothelial growth factor signaling.
Giorgetti-Peraldi S; Murdaca J; Mas JC; Van Obberghen E
Oncogene; 2001 Jul; 20(30):3959-68. PubMed ID: 11494124
[TBL] [Abstract][Full Text] [Related]
10. Involvement of rho p21 in cyclic strain-induced tyrosine phosphorylation of focal adhesion kinase (pp125FAK), morphological changes and migration of endothelial cells.
Yano Y; Saito Y; Narumiya S; Sumpio BE
Biochem Biophys Res Commun; 1996 Jul; 224(2):508-15. PubMed ID: 8702419
[TBL] [Abstract][Full Text] [Related]
11. Kaposi's sarcoma cells of different etiologic origins respond to HIV-Tat through the Flk-1/KDR (VEGFR-2): relevance in AIDS-KS pathology.
Morini M; Benelli R; Giunciuglio D; Carlone S; Arena G; Noonan DM; Albini A
Biochem Biophys Res Commun; 2000 Jun; 273(1):267-71. PubMed ID: 10873597
[TBL] [Abstract][Full Text] [Related]
12. A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells.
Takahashi T; Yamaguchi S; Chida K; Shibuya M
EMBO J; 2001 Jun; 20(11):2768-78. PubMed ID: 11387210
[TBL] [Abstract][Full Text] [Related]
13. Functionally active VEGF fusion proteins.
Backer MV; Backer JM
Protein Expr Purif; 2001 Oct; 23(1):1-7. PubMed ID: 11570839
[TBL] [Abstract][Full Text] [Related]
14. Chimeric VEGFRs are activated by a small-molecule dimerizer and mediate downstream signalling cascades in endothelial cells.
Knight EL; Warner AJ; Maxwell A; Prigent SA
Oncogene; 2000 Nov; 19(47):5398-405. PubMed ID: 11103941
[TBL] [Abstract][Full Text] [Related]
15. Autophosphorylation of KDR in the kinase domain is required for maximal VEGF-stimulated kinase activity and receptor internalization.
Dougher M; Terman BI
Oncogene; 1999 Feb; 18(8):1619-27. PubMed ID: 10102632
[TBL] [Abstract][Full Text] [Related]
16. Induction of KDR expression in bovine arterial endothelial cells by thrombin: involvement of nitric oxide.
Wang J; Morita I; Onodera M; Murota SI
J Cell Physiol; 2002 Feb; 190(2):238-50. PubMed ID: 11807828
[TBL] [Abstract][Full Text] [Related]
17. A potential autocrine role for vascular endothelial growth factor in prostate cancer.
Jackson MW; Roberts JS; Heckford SE; Ricciardelli C; Stahl J; Choong C; Horsfall DJ; Tilley WD
Cancer Res; 2002 Feb; 62(3):854-9. PubMed ID: 11830543
[TBL] [Abstract][Full Text] [Related]
18. Regulation of vascular endothelial growth factor receptor-2 (Flk-1) expression in vascular endothelial cells.
Pepper MS; Mandriota SJ
Exp Cell Res; 1998 Jun; 241(2):414-25. PubMed ID: 9637783
[TBL] [Abstract][Full Text] [Related]
19. VEGF receptor signaling and endothelial function.
Kliche S; Waltenberger J
IUBMB Life; 2001 Jul; 52(1-2):61-6. PubMed ID: 11795595
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro.
Grosskreutz CL; Anand-Apte B; Dupláa C; Quinn TP; Terman BI; Zetter B; D'Amore PA
Microvasc Res; 1999 Sep; 58(2):128-36. PubMed ID: 10458928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]